Colorectal Cancer Clinical Trials in Salt Lake City

Showing 41-60 of 271 trials

Improving Care for Rural Patients With Solid Tumors

NCT04916990

This study will assess if the CARES (Cancer Advocacy, Resources, Education and Support) intervention improves time to start of treatment after diagnosis and time to treatment completion for solid tumors (ex: lung, head, neck, thyroid, cervical, breast, bladder, colon, and rectal cancers) in rural patients.

Lung CancerHead and Neck CancerThyroid Cancer+5 more

University of Colorado, Denver320 participantsStarted Sep 2022

Aurora, Colorado, United States • Colorado Springs, Colorado, United States • Colorado Springs, Colorado, United States +11 more locations

RECRUITINGPhase 17.5 miles

A Study of MGC026 in Participants With Advanced Solid Tumors

NCT06242470

The study is designed to understand the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary antitumor activity of MGC026 in participants with relapsed or refractory, unresectable, locally advanced or metastatic solid tumors The study has a dose escalation portion and a cohort expansion portion of the study. Participants will receive MGC026 by intravenous (IV) infusion. The dose of MGC026 will be assigned at the time of enrollment. Participants may receive up to 35 treatments if there are no severe side effects and as long as the cancer does not get worse. Participants will be monitored for side effects, and progression of cancer, have blood samples collected for routing laboratory work, and blood samples collected for research purposes.

Advanced Solid TumorAdvanced CancerMetastatic Cancer+19 more

MacroGenics250 participantsStarted Mar 2024

Los Angeles, California, United States • Grand Rapids, Michigan, United States • Lake Success, New York, United States +9 more locations

Improving Care for Rural Patients With Solid Tumors

A Study of MGC026 in Participants With Advanced Solid Tumors

Colorectal Cancer Trials in Other Cities

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

Early Onset Colorectal Cancer Detection

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

EXoPERT EMERALD Clinical Study

Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

A Study of PHN-010 in Patients With Advanced Solid Tumors

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

Other Conditions in Salt Lake City